Pseudomonas Aeruginosa in Cystic Fibrosis
2 clinical trials · Condition
◉ Watch Pseudomonas Aeruginosa in Cystic Fibrosis
| Record | Firm | Date |
|---|---|---|
| Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs (NCT02449031) | Mylan Inc. | 2015-05-05 |
| Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis (NCT01519661) | Novartis Pharmaceuticals | 2012-01-01 |
Track Pseudomonas Aeruginosa in Cystic Fibrosis automatically
Every clearance here is in the API, with alerts when new ones post.